CD8A and rheumatoid arthritis: In CD8+ effector‐memory T cells, it increased liability to AS and HS, whereas in CD8+ naïve/central‐memory T cells, it was protective in RA and UC; in natural killer cells, it conferred risk in AS (Figure 1A).